Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
John B. Buse(University of North Carolina at Chapel Hill), Michael A. Nauck(Diabeteszentrum Bad Lauterberg), Thomas Först(Institut für Klinische Forschung und Entwicklung), Wayne H.-H. Sheu(National Yang Ming Chiao Tung University), Sylvia Shenouda(Eli Lilly (United States)), Cory R. Heilmann(Eli Lilly (United States)), Byron J. Hoogwerf(Eli Lilly (United States)), Aijun Gao(Cincinnati Health Department), Marilyn K Boardman(Eli Lilly (United States)), Mark Fineman, Lisa A. Porter, Guntram Schernthaner(Rudolfinerhaus Hospital)
Cited by 563
Abstract
Related Papers
No related papers found
Powered by citation graph analysis